Fiscal First Quarter 2023

Biotricity reports financial results for Fiscal 2023 First Quarter

REDWOOD CITY, Calif., Aug 15, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), ("Biotricity" or the "Company"), a medical diagnostic and…

Fiscal First Quarter 2023

Biotricity to host Fiscal First Quarter 2023 financial results conference call on August 15th at 4:30 p.m. ET

REDWOOD CITY, Calif., Aug 05, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Fourth Quarter update

Biotricity reports financial results for Fiscal 2022 fourth quarter and full year

REDWOOD CITY, Calif., Jul 14, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), ("Biotricity" or the "Company"), a medical diagnostic and…

Russel microcap

Biotricity to join Russell Microcap(R) Index

REDWOOD CITY, Calif., Jun 23, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Biotricity to present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th

REDWOOD CITY, Calif., May 23, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Shareholder Updates

Biotricity issues shareholder update

REDWOOD CITY, Calif., May 05, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Biotres

Biotricity to launch commercial sales of its disruptive cardiac monitoring device, Biotres in April 2022

REDWOOD CITY, Calif., Mar 22, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Biotricity named Fast Company

Biotricity named to Fast Company’s annual list of the World’s 50 Most Innovative Companies for 2022

REDWOOD CITY, Calif., Mar 08, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Biotricity, Inc. to attend 34th annual Roth Conference March 13th-15th

REDWOOD CITY, Calif., Mar 04, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Biotres - FDA cleared

Biotricity now taking pre-orders for its Biotres wireless wearable cardiac monitoring device

REDWOOD CITY, Calif., Feb 23, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Investor call

Biotricity releases Fiscal 2022 third quarter financial results

REDWOOD CITY, Calif., Feb 14, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…

Third Quarter Update

Biotricity to report third quarter fiscal 2022 financial results on February 14, 2022

REDWOOD CITY, Calif., Feb 08, 2022 (ACCESSWIRE) -- Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company,…